FDA grants priority review to Boehringer-Lilly’s Jardiance for heart failure
The FDA accepted an sNDA, which is based on data from the Phase III trial of the therapy.
Cardiovascular
Asia-Pacific has seen the largest growth in cardiovascular trials over the past decade
We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key...
Merck agrees to acquire Acceleron Pharma for $11.5bn
Merck will gain rights to Acceleron’s lead therapy candidate, sotatercept, intended to treat pulmonary arterial...
First successful trial in heart failure with preserved ejection fraction
According to the trial results, Jardiance reduces the risk of death or hospitalisation due to...
FDA grants approval to Boehringer-Lilly’s Jardiance to treat HFrEF
The approval is based on results from the global Phase III EMPEROR-Reduced trial in 3,730...
Hypertension: study suggests ARBs should be used before ACE inhibitors
Researchers found that while ACE inhibitors and ARBs are similarly beneficial, the latter carry a lower risk of side effects.
Exercise should be first line of defence against elevated blood pressure
Healthcare experts have recommended exercise as a first-line treatment for mild to moderate-risk blood pressure and cholesterol.
PharmaEssentia resubmits BLA for polycythemia vera therapeutic
PharmaEssentia USA resubmits BLA to the FDA, seeking approval for ropeginterferon alfa-2b-njft for polycythemia vera treatment.
Israel assesses myocarditis cases linked to Pfizer-BioNTech Covid-19 vaccine
The Israel Health Ministry is examining a small number of cases related to inflammation of the heart muscle in individuals inoculated with Pfizer and BioNtech’s Covid-19 vaccine.
A segment of Covid-19 survivors face possible long-term complications
There is growing evidence that about 10% of people with Covid-19 will go on to experience 'long Covid', where symptoms such as fatigue, shortness of breath, fevers, gastrointestinal issues, sleep disorders, 'brain fog', anxiety, post-traumatic...
Heart Disease Deaths on the Rise in Young Women
As February is American Heart Month in the US, GlobalData epidemiologists are highlighting findings from a nationwide study on premature heart disease and cancer-related deaths in young women, published mid-February in the 'European Heart Journal...
